Rahimtoola S H
Ann Intern Med. 1982 Sep;97(3):433-9. doi: 10.7326/0003-4819-97-3-433.
Valve replacement is the most important advance in the management of patients with valvular heart disease, but it cannot be recommended to all patients with valve disease. Cardiac catheterization and angiography, done before surgery, yield valuable and essential information in evaluating these patients. The claim of certain studies that cardiac catheterization and angiography are not needed in these patients cannot be accepted because: The experimental method of these studies was inappropriate; the accuracy and reproducibility of noninvasive techniques in diagnosing the presence and severity of all valve lesions, coronary arterial obstruction, and prosthetic malfunction are not documented; and the studies provide no proof that patients with severe valve disease were not denied surgery, and that patients with mild disease did not have unnecessary operations. Prospective studies that are well designed, well conducted, and scientifically sound are needed. Cardiac catheterization and angiography remain the standard techniques for evaluating patients for valve replacement.
瓣膜置换术是心脏瓣膜病患者治疗方面最重要的进展,但并非所有瓣膜病患者都适合接受该手术。术前进行的心导管检查和血管造影,可为评估这些患者提供有价值且至关重要的信息。某些研究称这些患者无需进行心导管检查和血管造影,这种说法不能被接受,原因如下:这些研究的实验方法不合适;无创技术在诊断所有瓣膜病变、冠状动脉阻塞和人工瓣膜功能障碍的存在及严重程度方面的准确性和可重复性尚无文献记载;而且这些研究没有证明严重瓣膜病患者未被拒绝手术,以及轻症患者没有接受不必要的手术。需要设计良好、实施得当且科学合理的前瞻性研究。心导管检查和血管造影仍然是评估患者是否适合进行瓣膜置换术的标准技术。